PABA, or para-aminobenzoic acid, did show an ability to temporarily darken gray hair in a widely cited mid-twentieth-century study, but the effect disappeared within weeks of stopping the supplement, the mechanism was never identified, and the doses involved carry real safety risks. The science here is thinner than the supplement marketing suggests. A systematic review of all medications reported to repigment gray hair classified the evidence for PABA and similar vitamin supplements as low-quality, and no modern clinical trial has revisited the question with the rigor it would need to produce a recommendation.
The Study That Started It All
Almost everything you read online about PABA and gray hair traces back to a single finding: in a study of 460 gray-haired individuals, taking 100 mg of PABA three times daily caused hair darkening in roughly 82 percent of participants within two to four months. That sounds impressive until you read the next line. When participants stopped taking the supplement, the color faded back to gray within two to four weeks.1PubMed. Premature graying of hair The effect was temporary, fully reversible, and dependent on continuous high-dose supplementation.
That study was conducted decades ago, and its design would not meet today’s standards for drawing conclusions about a treatment. There was no placebo control group, no blinding, and no objective measurement of how much color actually returned versus how much participants or observers perceived. The 82 percent figure gets repeated across supplement websites as though it is settled science, but it comes from a single uncontrolled observation. No subsequent trial with modern methodology has tried to replicate it. The review article that discusses PABA’s role in gray hair repigmentation explicitly notes that the mechanism of action is unknown.1PubMed. Premature graying of hair
Why Hair Goes Gray in the First Place
To understand why PABA’s supposed effect is so hard to explain, it helps to know what actually drives graying. Hair color comes from melanin, a pigment produced by specialized cells called melanocytes that sit at the base of each hair follicle. Those melanocytes are replenished over a person’s lifetime by a pool of melanocyte stem cells that live in a region of the follicle called the bulge. As long as those stem cells keep producing new melanocytes, each new hair that grows in will carry pigment.
Research using both mouse models and human hair follicles has demonstrated that graying results from a failure of those stem cells to maintain themselves. Over time, the stem cell pool shrinks, fewer melanocytes are produced, and new hairs grow in without pigment.2PubMed. Mechanisms of hair graying: incomplete melanocyte stem cell maintenance in the niche More recent work has shown that reactive oxygen species, the damaging molecules that accumulate as a byproduct of normal metabolism, play a role in exhausting this stem cell population. When a gene involved in mitochondrial function was disrupted in mice, the resulting spike in oxidative stress caused melanocyte stem cells to die off and hair to turn gray prematurely.3PubMed Central. Mitochondrial deoxyguanosine kinase depletion induced ROS causes melanocyte stem cell exhaustion and hair greying
This distinction matters. The graying in those mice was not caused by melanocytes losing the ability to make pigment; the melanocytes themselves were being lost. If PABA were simply boosting melanin production in existing melanocytes, that would be one kind of effect. But if the underlying problem is that the stem cells feeding new melanocytes into the hair follicle are depleted, boosting pigment output in a shrinking pool of cells would produce diminishing returns and would explain why any darkening effect disappears the moment supplementation stops.
Why Nobody Knows How PABA Would Work
PABA is a B-vitamin-related compound, sometimes grouped loosely with the B-complex family. It is a precursor molecule in the synthesis of folic acid by bacteria in the gut, and it has a long history of investigation for various biological activities, including a possible role in pigmentation. But “possible role” is doing a lot of heavy lifting. The actual mechanism by which PABA might influence hair color in humans has never been identified.
One hypothesis floated over the years involves PABA’s relationship to folic acid and broader B-vitamin metabolism. Deficiencies in B12, folate, and other B vitamins have been associated with premature graying, and correcting those deficiencies sometimes leads to repigmentation. The idea is that PABA, by supporting folate production, might indirectly improve conditions for melanin synthesis. But this remains speculative. No study has demonstrated a causal chain from PABA supplementation through folate levels to melanocyte activity in human hair follicles.
A systematic review that catalogued every medication reported to cause repigmentation of gray hair identified PABA alongside a grab bag of unrelated drugs, from anti-inflammatory medications to cancer drugs to glaucoma eyedrops. The review noted that the evidence base was predominantly low-quality, consisting of case reports and uncontrolled studies.4PubMed Central. Medication-Induced Repigmentation of Gray Hair: A Systematic Review PABA falls squarely into that low-quality bracket. The compound has a physiological plausibility that keeps it alive in the conversation, but plausibility without modern clinical evidence is where a lot of supplement claims live and stay.
Safety Concerns at the Doses Reported to Work
The dose used in the original study was 300 mg per day (100 mg three times daily). That is well above what you would encounter in a standard multivitamin, and PABA at high doses is not a harmless compound. It has been associated with liver toxicity, particularly in its potassium salt form (potassium para-aminobenzoate, sold under the brand name Potaba) used to treat Peyronie’s disease and some fibrotic skin conditions.
Case reports have documented acute liver injury in patients taking potassium para-aminobenzoate. In one published case, a patient developed right-sided abdominal pain and significantly elevated liver enzymes after starting treatment. The condition resolved after stopping the drug.5PubMed Central. Rare Incidence of Acute Liver Injury with Potassium Para-Aminobenzoate Introduction Additional cases of acute hepatitis linked to potassium para-aminobenzoate have been reported in the medical literature.6The Journal of Sexual Medicine. Acute Hepatitis Associated with Treatment of Peyronie’s Disease with Potassium Para‐Aminobenzoate (Potaba)
Other reported side effects of high-dose PABA include nausea, vomiting, diarrhea, and skin rash. PABA also interferes with sulfonamide antibiotics, an interaction that has been known since the 1940s and is the reason PABA was one of the first compounds studied in early antibiotic research. If you are taking any sulfa-based medication, PABA supplementation could reduce its effectiveness.
The risk-benefit calculation here is unfavorable. You would need to take a moderately high dose of a compound with documented liver toxicity, continue indefinitely because the effect vanishes within weeks of stopping, all based on decades-old evidence from a single uncontrolled study. No mainstream dermatology guideline recommends PABA supplementation for gray hair reversal.
PABA’s Broader History and Fall from Favor
PABA once had a much larger presence in everyday life, not as a hair supplement but as a sunscreen ingredient. Throughout the 1970s and 1980s, PABA and its derivatives were among the most common UV-absorbing chemicals in sunscreen formulations. They were effective at blocking UVB radiation, but they brought problems.
Patch testing studies revealed that PABA was a relatively common contact allergen and photoallergen, meaning it could cause skin reactions on its own or, more troublingly, skin reactions triggered by sun exposure. In one study examining reactions to sunscreen ingredients, PABA was identified as the allergen in about half the patients tested.7Photo-dermatology. Contact and photocontact allergy to sunscreens It also stained clothing yellow and had a tendency to degrade in sunlight, reducing its effectiveness over time. By the early 2000s, PABA and its derivatives had been largely phased out of commercial sunscreens in favor of newer UV filters with better safety profiles.8British Journal of Dermatology. Photoallergic contact dermatitis is uncommon
The sunscreen chapter is worth mentioning because it illustrates a pattern. PABA was once enthusiastically adopted based on one clear property (UV absorption), only to be abandoned once its side effects became clear and alternatives emerged. The gray-hair story follows a similar arc, minus the widespread adoption: a promising early finding, no mechanistic explanation, safety concerns, and quiet retreat from the scientific conversation.
Other Substances That Can Restore Some Hair Color
PABA is not the only compound reported to darken gray hair. The same systematic review that included PABA found 27 studies describing medication-induced repigmentation, spanning anti-inflammatory drugs, melanin-stimulating medications, and vitamin supplements.4PubMed Central. Medication-Induced Repigmentation of Gray Hair: A Systematic Review Most of these were incidental observations: a patient was being treated for something else entirely and their gray hair happened to darken. Only six of the 27 studies examined repigmentation as a primary goal.
Among the medications reported to trigger repigmentation as an incidental side effect were drugs that work by stimulating melanocyte activity or suppressing immune-mediated damage to melanocytes. Latanoprost, a glaucoma eyedrop, is a well-known example: it can darken eyelashes and sometimes the iris. Imatinib, a cancer drug, has been reported to cause hair repigmentation in some patients. Levodopa, used for Parkinson’s disease, has a more intuitive link since it is a precursor to melanin.
None of these drugs are prescribed for gray hair, and their repigmentation effects are inconsistent and unpredictable. But they do demonstrate that hair color can sometimes be restored, at least partially and temporarily, under specific pharmacological conditions. The challenge is that these conditions typically involve powerful drugs with their own significant side effects, and the repigmentation is rarely complete or permanent.
When Gray Hair Actually Does Reverse on Its Own
There is growing evidence that graying is not always a strict one-way street, at least in the early stages. Researchers have documented individual hairs that transition from gray back to pigmented without any pharmaceutical intervention. These observations tend to occur in people who are relatively young and in the early phases of graying, when the melanocyte stem cell pool in a given follicle may not yet be fully exhausted.
Stress has emerged as one factor that can accelerate graying and, when removed, sometimes allow partial reversal. A 2021 study from Columbia University mapped individual hairs and found that some hairs that went gray during periods of documented psychological stress regained pigment when the stress resolved. This phenomenon was limited to hairs in a transitional state, hairs that had been gray for years did not spontaneously repigment.
This connects back to the biology described earlier. If a hair follicle still has a viable population of melanocyte stem cells, those cells might be temporarily suppressed by stress-related signaling, oxidative damage, or other reversible insults. Remove the insult, and pigment production can resume. But once the stem cell pool in a given follicle is depleted beyond a certain threshold, no amount of stress reduction or supplementation is going to bring color back to that follicle. The difference between a follicle in the gray “transition zone” and one that has been gray for years may explain why PABA seemed to work in some people and not others, though this is speculation rather than demonstrated science.
The B-Vitamin Connection and Premature Graying
Where PABA supplementation for gray hair may have a grain of legitimate science behind it is in the subset of people who are going gray prematurely due to nutritional deficiency. Deficiencies in vitamin B12, folate, biotin, and vitamin D have all been linked to premature graying, and correcting these deficiencies can sometimes lead to partial repigmentation. The systematic review noted low-quality evidence that B-complex supplementation can promote gray hair darkening.4PubMed Central. Medication-Induced Repigmentation of Gray Hair: A Systematic Review
If someone’s graying is driven partly by inadequate B-vitamin status, and if PABA is contributing to improved folate metabolism in their gut, there is a plausible pathway by which PABA supplementation could help. But this would be an indirect nutritional correction, not a direct anti-graying drug effect. It would also apply only to the minority of people whose graying has a nutritional component, not to the vast majority whose graying is driven by genetics and aging.
A blood test for B12 and folate levels costs little and provides actual diagnostic information. If those levels are low, correcting them with established supplements at standard doses is safer, cheaper, and better supported than taking high-dose PABA on the hope that it might help through an unknown mechanism. For people with normal B-vitamin levels, the nutritional rationale for PABA evaporates.
What the Supplement Market Gets Wrong
PABA remains available as a dietary supplement, often marketed with language that stops just short of promising gray hair reversal. The typical framing mentions the old study, cites the 82 percent figure without context, and avoids discussing the relapse rate, the lack of replication, or the safety concerns. Some products combine PABA with other B vitamins, copper, and antioxidants in “gray hair formulas” that treat PABA as one ingredient in a broader strategy.
Copper is included in some of these formulas because tyrosinase, the enzyme that initiates melanin production, requires copper as a cofactor. The logic is that supplemental copper might boost melanin output. But copper deficiency severe enough to impair melanin production is rare in people eating a normal diet, and excess copper supplementation carries its own toxicity risks including liver damage. Adding copper to a PABA formula does not create a synergistic anti-graying cocktail; it creates two compounds with hepatotoxicity potential in one pill.
The broader issue is that hair graying involves a complex interplay of genetics, oxidative stress, stem cell biology, and hormonal signaling. The idea that a single supplement, or even a combination of supplements, can meaningfully reverse this process in a genetically typical adult with age-appropriate graying has no solid support. The research that does exist on repigmentation involves either powerful prescription drugs with serious side effects, correction of genuine nutritional deficiencies, or reduction of extreme psychological stress, none of which are captured in a PABA capsule from a health food store.